Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Upsalite is not considered to be irritating to the skin and main constituents are not considered to be irritating to the eyes.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 08/05/2018-11/05/2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Reconstructed Human Epidermis Test Method - adopted in 2013
Method followed: In Vitro EpiDermTM Skin Irritation Test (EPI-200-SIT) with Reconstructed Human
Epidermal Model - GLP compliance:
- yes
- Specific details on test material used for the study:
- Q0002-1701
- Test system:
- other: reconstructed Human Epidermal Model.
- Vehicle:
- not specified
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- ca. 85.2
- Vehicle controls validity:
- not specified
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- According to the EU and GHS classification (R38/Category 2 or no label), an irritant is predicted if the mean relative tissue viability of three individual tissues exposed to the test substance is reduced below 50% of the mean viability of the negative controls.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to results obtained from this test implementation, the viability of Reconstructed human epidermal model is > 50%. The product: UPSALITE Q0002-1701 is classified as: NI (Not Irritant)/not required classification.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation, other
- Remarks:
- ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15.3.2015-16.3.2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted according to Guidelines in a GLP-certified laboratory
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- Self-certified
- Specific details on test material used for the study:
- Identification: Magnesium hydroxide
Molecular formula: Mg(OH)2
Molecular weight: 58.32 - Species:
- other: Bovine
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- Bovine eyes from young cattle were obtained from the slaughterhouse, where the eyes were excised by a slaughterhouse employee as soon as possible after slaughter. The eyes were collected and transported in physiological saline in a suitable container and were used within 30 minutes.
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent no treatment
- Amount / concentration applied:
- Unknown
- Duration of treatment / exposure:
- topical treatment for 240 ± 10 minutes
- Observation period (in vivo):
- After incubation with the test substance, the solutions were removed, fresh cMEM was added and an opacitiy determination was performed without any further incubation
- Number of animals or in vitro replicates:
- Three corneas were used in each treatment group
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing: After the incubation with the test substance, corneas were washed at least 3 times with cMEM prior to determination of opacity
- Time after start of exposure: 240 ± 10 minutes
OPACITY:
The opacitometer determined the difference in light transmission between each control and treated cornea and an air filled chamber. The numerical opacity value was displayed and recorded. The change in opacity for each individual cornea was calculated by subtracting the initial opacity reading from the post-treatment reading. The corrected opacity was calculated by subtracting the opacity of the negative control.
PERMEABILITY
Following the final opacity method, permeability of the cornea to Na-fluorescein was evaluated. The medium of both compartments (anterior compartment first) was removed. The posterior compartment was refilled with fresh cMEM. The anterior compartment was filled with 1 ml of Na-fluorescein solution. The corneas were completely covered and were incubated in a horizontal position for 90 ± 5 minutes at 37 ± 1 °C.
After the incubation period, the medium in the posterior compartment of each holder was removed and placed into a sampling tube labelled according to holder number. 360 µl of the medium from each sampling tube was transferred to a 96-well plate. The optical density at 490 nm of each sampling tube was measured in triplicate using a microplate reader. - Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- other: 240 min
- Score:
- ca. 5.1
- Max. score:
- 7.1
- Remarks on result:
- other: in vitro irritancy score
- Irritation parameter:
- other: Opacity
- Basis:
- mean
- Time point:
- other: 240 min
- Score:
- ca. 5
- Max. score:
- 7
- Irritant / corrosive response data:
- See " Any other information on results incl. tables".
- Other effects:
- ND
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Not irritating
- Conclusions:
- Since the mean in vitro irritancy score for Magnesium Hydroxide was below 55.1 after 240 minutes treatment, Magnesium Hydroxide is not classed as an irritant in the BCOP test.
- Executive summary:
Screening for the eye irritancy potential of Magnesium hydroxide using the BCOP test. The study procedures were based on OECD guidelines. Magnesium hydroxide did not induce ocular irritation through both endpoints, resulting in a meanin vitroirritancy score of 5.1 after 240 minutes of treatment. Since this score is below 55.1 after 240 minutes treatment, Magnesium hydroxide is not classified as an irritant in the BCOP test.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular Corrosives and Severe Irritants)
- Principles of method if other than guideline:
- Instead of using fresh bovine corneas, four laboratories (laboratories 2, 3, 8 and 10), agreed to perform the experiments with preserved corneas. It was of particular interest to know whether both tissues would respond similarly to chemical injury. In some locations, it was sometimes difficult to get the eyes early enough in the morning to run a long experiment with solid substances (4-hr incubation). L'Orral has routinely used both fresh and preserved corneas and similar results were obtained (M. Cottin, personal communication, 1991). The protocol used to preserve corneas was the following. Corneas were dissected as usual with a 2-3-mm scleral rim. They were then washed three times, each for 15 min, in HBSS supplemented with antibiotics (penicillin/streptomycin, 100 U/100/ag per ml). After rinsing in normal HBSS, they were placed individually into wells of six-well culture plates, each of them containing 12 ml preservative medium. The latter consisted of M 199 medium (Sigma M-3769) containing 5% (w/v) dextran (Sigma D-1662; mol. wt 40,000), adjusted to pH 7.4, and prepared daily. Plates were then placed in the refrigerator at 4-5°C until the next day. For use, the plates were removed from the refrigerator and left on the bench for 30 min at room temperature and the corneas were mounted in holders and filled with MEM. The next steps were identical to those used for fresh corneas
- GLP compliance:
- not specified
- Specific details on test material used for the study:
- Test material is from Aldrich
- Species:
- other: Bovine
- Details on test animals or tissues and environmental conditions:
- Bovine eyes were collected from a commercial abattoir in a plastic jar containing 1 litre HBSS for approximately 25 eyes.Buffer storage and eyes transportation to the laboratorieswere performed at ambient temperature, and the eyes were used within 2 hr of the killing of the animals. During dissection great care was taken to avoid damage of corneal surfaces (epithelial and endothelial). Each cornea was carefully examined,and those presenting defects, such as neovascularization, pigmentation, opacity or scratches were discarded.Globes were first dissected free of surrounding tissues and placed in a jar containing fresh HBSS. Selected corneas were dissected with a 2-3-mm rim of sclera for easier handling, and stored in a petri dish containing HBSS until use. Corneas were then mounted in holders filled with MEM, and incubated for 1 hr in a water-bath at 32°C.
- Vehicle:
- other: MEM; minimum essential medium
- Controls:
- yes, concurrent vehicle
- Amount / concentration applied:
- Solids were prepared as an approximate 20% solution or suspension (200mg+lml) in MEM using a mortar and pestle for homogeneous preparations, and a volume of 0.75 ml was applied on the epithelium with an appropriate syringe and needle.
- Duration of treatment / exposure:
- Solid test substances are incubated at 32 ± 1°C for 240 ± 10 minutes. The compound was then removed and the epithelium was washed at least three times (until thecornea was free of particles; gentle swirling movementsof the holders were sometimes necessary) with approximately 4ml medium.
- Duration of post- treatment incubation (in vitro):
- Both compartments were refilled with medium, and opacity measurement was performed immediately without any further incubation.
- Number of animals or in vitro replicates:
- Table summarizes the results obtained for test substances by the 11 laboratories. Each value represents the mean in vitro score from six corneas.
A mean in vitro score from all laboratories was also calculated. - Details on study design:
- SELECTION AND PREPARATION OF CORNEAS
:
Bovine eyes are typically obtained from a local cattle abattoir, where the eyes are excised as soon as possible after sacrifice. Care should be taken to avoid damaging the cornea during the enucleation procedure. Eyes are collected in a suitable container in which they are immersed in HBSS containing the antibiotics penicillin (100 IU/mL) and streptomycin (100 μg/mL) .The eyes are used within five hours of sacrifice.
QUALITY CHECK OF THE ISOLATED CORNEAS :
Carefully is examined all eyes macroscopically. Those exhibiting unacceptable defects, such as opacity, scratches, pigmentation, and neovascularization are rejected.Carefully remove the cornea from each selected eye by making an incision with a scalpel 2 to 3 mm outside the cornea, then by cutting around the cornea with dissection scissors, leaving a rim of sclera to facilitate handling. Carefully peel off the iris and lens, ensuring no fragments of these tissues are remaining on the cornea. Take care to avoid damaging the corneal epithelium and endothelium during dissection. Store the isolated corneas in a petri dish containing HBSS until they are mounted in holders. Examine the corneas before use, and discard those with defects. Mount the corneas in holders (one cornea per holder) by placing the endothelial side of the cornea against the O-ring of the posterior chamber. Place the anterior chamber over the cornea and join the chambers together by tightening the chamber screws. Care should be taken not to shift the two chambers to avoid damaging the cornea. Fill both chambers with fresh complete MEM (about 5 mL), always filling the posterior chamber first to return the cornea to its natural curvature. Care should be taken when adding or removing liquid from the posterior chamber to avoid the formation of bubbles and to minimize shear forces on the corneal endothelium. Seal each chamber with plugs provided with the holders. Incubate the holders in a vertical position at 32 ± 1°C for at least 60 minutes. At the end of the initial 1-hour incubation period, examine each cornea for defects, such as tears or wrinkling. Discard corneas with any observed defects.
NUMBER OF REPLICATES : minimum of three corneas
SOLVENT CONTROL USED (if applicable)
APPLICATION DOSE AND EXPOSURE TIME
TREATMENT METHOD: Solid nonsurfactant test substances:Solid test substances are tested on the cornea as a 20% (w/v) solution or suspension prepared in an appropriate solvent/vehicle.
Solid test substances are incubated at 32 ± 1°C for 240 ± 10 minutes.
POST-INCUBATION PERIOD: no, Thus, immediately following the rinsing process, both chambers are refilled (posterior chamber first) with fresh complete MEM, and the post-treatment opacity readings are taken. During the post-treatment opacity reading, visual observations are performed for each cornea and, if necessary, are recorded in the workbook.
METHODS FOR MEASURED ENDPOINTS:
In the BCOP test method, changes in corneal opacity caused by chemical damage are determined by measuring decreases in light transmission through the cornea. Changes in permeability of the cornea resulting from chemical damage are determined by measuring increases in the quantity of sodium fluorescein dye that passes through all corneal cell layers.
Opacity measurement. The opacitometer (Electro-Design, Riom, France) determines the difference inlight transmission between a treated and a control cornea, and displays a numerical opacity value (arbitrary units). The apparatus was previously calibrated with standardized opaque sheets of polyester, and values obtained with test substances generally ranged between 0 and 150.
Permeability. This second step of the assay wasperformed immediately after the measurement of opacity. The medium was again removed from both chambers of holders, and replaced by fresh medium in the posterior compartment, and by 1 ml fluorescein solution (0.4% for liquids and surfactants, 0.5% for solids) in contact with the epithelium. Corneas were then incubated in a horizontal position for 90 min at 32°C. Medium from the posterior chamber was then removed, and its optical density (O.D.) determined with a spectrophotometer at 490 nm.
For each substance evaluated, the mean value of opacity + SD and the mean value of permeability (expressed as O.D. units + SD) were calculated. An in vitro score for irritancy combining both parameters was also
calculated using the following formula:In vitro score = opacity value + 15 times O.D. valueScoring: Alternatively, compounds can be classified more simply as irritating (moderate plus severe, i.e. score ~>25.1) or non-irritating (mild, i.e. score ~<25.0),
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 6
- Value:
- ca. 3
- Vehicle controls validity:
- not specified
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 6
- Value:
- ca. 6
- Vehicle controls validity:
- not specified
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 6
- Value:
- ca. 0
- Vehicle controls validity:
- not specified
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 6
- Value:
- ca. 1
- Vehicle controls validity:
- not specified
- Irritation parameter:
- cornea opacity score
- Run / experiment:
- 6
- Value:
- ca. 7
- Vehicle controls validity:
- not specified
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Mean score 3, reversibility 3 days.
Agreement between laboratories when data are grouped in two classes (non-irritant, score < 25.0; irritant score /> 25.1). The results of all laboratories ; non-classified.
Referenceopen allclose all
Table 1 Summary of opacity, permeability and in vitro scores
Treatment |
Mean Opactiy |
Mean Permeability |
MeanIn vitroIrritation Score1,2 |
Negative control | 0 | 0.000 | 0.0 |
Positive control | 80 | 2.490 | 117 |
Magnesium hydroxide | 5 | 0.006 | 5.1 |
1. Calculated using the negative control mean opacity an mean permeability values.
2. In vitro irritancy score (IVIS)= mean opacity + (15X mean OD490value).
Table 2. Opacity score
Eye |
Opacity before treatment |
Opacity after treatment |
Final opacity |
Negative control corrected final opacity |
Mean opacity |
Negative control |
|||||
1 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
1 |
1 |
1 |
|
3 |
0 |
0 |
0 |
0 |
|
Positive control |
|||||
4 |
0 |
80 |
80 |
80 |
80 |
5 |
0 |
79 |
79 |
79 |
|
6 |
0 |
81 |
81 |
81 |
|
Magnesium hydroxide |
|||||
10 |
0 |
6 |
6 |
6 |
5 |
11 |
0 |
3 |
3 |
3 |
|
12 |
0 |
7 |
7 |
7 |
|
Table 3. Permeability score (corrected)
e |
Dilution factor |
Corrected OD4901 |
Corrected OD4902 |
Corrected OD4903 |
Average OD490 |
Final OD490 |
Average OD |
Negative control |
|||||||
1 |
1 |
0.014 |
0.001 |
0.004 |
0.006 |
0.006 |
0.000 |
2 |
1 |
0.000 |
0.000 |
0.003 |
0.001 |
0.001 |
|
3 |
1 |
-0.001 |
-0.008 |
-0.009 |
-0.006 |
-0.006 |
|
Positive control |
|||||||
4 |
6 |
0.369 |
0.366 |
0.372 |
0.369 |
2.214 |
2.490 |
5 |
6 |
0.349 |
0.362 |
0.354 |
0.355 |
2.130 |
|
6 |
6 |
0.527 |
0.518 |
0.519 |
0.521 |
3.126 |
|
Magnesium hydroxide |
|||||||
10 |
1 |
0.008 |
0.008 |
0.011 |
0.009 |
0.009 |
0.006 |
11 |
1 |
0.008 |
0.002 |
0.000 |
0.003 |
0.003 |
|
12 |
1 |
0.006 |
0.004 |
0.005 |
0.005 |
0.005 |
Table 4. In vitro irritancy score
Eye |
Negative control corrected final opacity |
Negative control corrected final OD490 |
In vitro irritancy score |
Negative control |
|||
1 |
0 |
0.006 |
0.1 |
2 |
0 |
0.001 |
1.0 |
3 |
0 |
-0.006 |
-0.1 |
Positive control |
|||
4 |
80 |
2.214 |
113.2 |
5 |
79 |
2.130 |
111.0 |
6 |
81 |
3.126 |
127.9 |
Magnesium hydroxide |
|||
10 |
6 |
0.009 |
6.1 |
11 |
3 |
0.003 |
3.0 |
12 |
7 |
0.005 |
7.1 |
In vitro irritancy score (IVIS) = mean opacity + (15 x mean OD490value)
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Justification for classification or non-classification
In thein vitro skin irritation (upsalite )and the in vivo eye irritation studies, magnesium carbonate and magnesium hydroxide were non-irritant and therefore requires no classification under the CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.